𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia

✍ Scribed by Kavuru, S; Patel, D; Janson, D; Driscoll, N; Ahmed, S; Rai, K R; Gupta, N


Book ID
110055232
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
118 KB
Volume
16
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Rituximab therapy for chronic lymphocyti
✍ Giovanni D'Arena; Luca Laurenti; Silvana Capalbo; Alfonso Maria D'Arco; Rosaria πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

Autoimmune hemolytic anemia (AIHA) is a well-known complication of chronic lymphocytic leukemia (CLL). In recent years the anti-CD20 monoclonal antibody rituximab has been used for the therapy of steroid-refractory AIHA and autoimmune thrombocytopenia, either idiopathic or in association with CLL. W